News
MedPage Today on MSN2d
Ozempic Shows Benefit in Type 1 Diabetes Patients With ObesityCHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...
MedPage Today on MSN2d
Mifepristone Helped Control Diabetes in Those With HypercortisolismCHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...
HealthDay on MSN15h
ADA: Weight Loss, Type 2 Diabetes Remission Up With Replacing Diet Drinks With WaterFor adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...
Results presented at the 85th Scientific Sessions of the American Diabetes Association in Chicago highlight the potential for ...
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) American Diabetes Association (ADA) 85th Scientific Sessions Conference June 20, 2025 8:15 PM ET James Markmann - Corporate Participant Michael ...
HealthDay on MSN15h
ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 DiabetesThe oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 ...
Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback